All Articles


The Importance of Patient Education: A Nurse’s Perspective
It is exciting to see that patients with advanced breast cancer are able to receive additional treatment options, because a primary concern of patients with stage IV breast cancer is a lack of awareness of laboratory and clinical research targeted for those battling advanced disease.
Read More

Increasing Focus on Value Related to Cancer Drugs: A Payer Perspective
Based on the prevalence of invasive breast cancer, the amount of drug therapy required among a managed patient population is considerable, and significantly affects the top cancer trend therapies within the cancer budget for payers.
Read More

Treatment of Advanced Breast Cancer: A Clinical Pharmacy Perspective
At the Markey Cancer Center in Lexington, KY, clinical pharmacists are integral members of the multidisciplinary care team, working in the clinic alongside surgical and medical oncologists, imaging specialists, radiation oncologists, pathologists, nurses, and other healthcare providers.
Read More

I’ve just returned from our West Coast Regional Meeting, where attendees enjoyed a robust agenda featuring speakers from across the oncology community. I cannot help but feel re-energized in our mission to advance the cause of navigation!
Read More


In this latest installment of the Evidence into Practice series, Ms. Bellomo discusses the responsibilities of navigators as they relate to the guiding principles of navigation to include quality, confidentiality, and professionalism.
Read More

The authors present a case demonstrating the responsibilities of the navigator on the multidisciplinary team to include ensuring timeliness of care, care coordination, addressing barriers to care, program evaluation, and process improvement.
Read More

A case showing how navigation is integral to facilitate effective interprofessional collaboration and promote patient satisfaction and quality of care, as well as the efficient use of healthcare resources.
Read More

The addition of cisplatin to standard therapy with gemcitabine and nab-paclitaxel was associated with a median overall survival that “has not been seen in stage IV pancreatic cancer,” according to Gayle Jameson, MSN, ACNP-BC, Nurse Practitioner Investigator of Clinical Trials, HonorHealth Research Institute, Scottsdale, AZ.
Read More

Page 225 of 281

Journal of Oncology Navigation & Survivorship
JONS

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
    Profession or Role
    Primary Specialty or Disease State
    Country